Colchicine today

Joint Bone Spine

Volumn 73, Issue 6, 2006, Pages 672-678

  Niel, Elisabeth ^a   Scherrmann, Jean Michel ^a  

^a CNRS   (France)

Author keywords

Colchicine; Drug drug interactions; P glycoprotein; Pharmacokinetics; Variability

Indexed keywords

ALBUMIN; COLCHICINE; CYTOCHROME P450 3A4; GLYCOPROTEIN P; TUBULIN; UNINDEXED DRUG;

ABDOMINAL PAIN; ALOPECIA; ANOREXIA; BILIARY EXCRETION; DIARRHEA; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; DRUG FATALITY; DRUG HALF LIFE; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG TRANSFORMATION; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE; MUSCLE DISEASE; MYALGIA; NONHUMAN; RADIOIMMUNOLOGY; REGULATORY MECHANISM; SHORT SURVEY; STEADY STATE; SYSTEMATIC REVIEW; TISSUE DISTRIBUTION; URINARY EXCRETION;

COLCHICINE; GOUT; GOUT SUPPRESSANTS; HUMANS; INFLAMMATION;

EID: 33845579871     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.03.006     Document Type: Short Survey

References (59)

1. Ben Chetrit E., and Levy M. Colchicine: 1998 update. Semin. Arthritis Rheum. 28 (1998) 48-49
2. Ben Chetrit E., Fischel R., Hinz B., and Levy M. The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2. Rheumatol. Int. 25 (2005) 332-335
3. Sato Y., Arai N., Negishi A., and Ohya K. Expression of cyclooxygenase genes and involvement of endogenous prostaglandin during osteogenesis in the rat tibial bone marrow cavity. J. Med. Dent. Sci. 44 (1997) 81-82
4. Roberts W.N., Liang M.H., and Stern S.H. Colchicine in acute gout. Reassessment of risks and benefits. JAMA 257 (1987) 1920-1922
5. Gilbert C., Poubelle P.E., Borgeat P., Pouliot M., and Naccache P.H. Crystal-induced neutrophil activation: VIII. Immediate production of prostaglandin E2 mediated by constitutive cyclooxygenase 2 in human neutrophils stimulated by urate crystals. Arthritis Rheum. 48 (2003) 1137-1148
6. Ben Chetrit E., and Levy M. Familial Mediterranean fever. Lancet 351 (1998) 659-664
7. Hazen P.G., and Michel B. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome. Arch. Dermatol. 115 (1979) 1303-1306
8. Adler Y., Zandman-Goddard G., Ravid M., Avidan B., Zemer D., Ehrenfeld M., et al. Usefulness of colchicine in preventing recurrences of pericarditis. Am. J. Cardiol. 73 (1994) 916-917
9. Kaplan M.M., Alling D.W., Zimmerman H.J., Wolfe H.J., Sepersky R.A., Hirsch G.S., et al. A prospective trial of colchicine for primary biliary cirrhosis. N. Engl. J. Med. 315 (1986) 1448-1454
10. Marwaha R.K., Singh R.P., Garewal G., Marwaha N., Prakash D., and Sarode R. Colchicine therapy in immune thrombocytopenic purpura. Acta Paediatr. Scand. 79 (1990) 1118-1120
11. Bibas R., Gaspar N.K., and Ramos-e-Silva M. Colchicine for dermatologic diseases. J. Drugs Dermatol. 4 (2005) 196-204
12. Alarcon-Segovia D., Ramos-Niembro F., Ibanez D.K., Alcocer J., and Tamayo R.P. Long-term evaluation of colchicine in the treatment of scleroderma. J. Rheumatol. 6 (1979) 705-712
13. Kaidbey K.H., Petrozzi J.W., and Kligman A.M. Topical colchicine therapy for recalcitrant psoriasis. Arch. Dermatol. 111 (1975) 33-36
14. Witko-Sarsat V., Sermet-Gaudelus I., Lenoir G., and Descamps-Latscha B. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?. Mediators Inflamm. 8 (1999) 7-11
15. Sermet-Gaudelus I., Stoven V., Annereau J.P., Witko-Sarsat V., Reinert P., Guyot M., et al. Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report. Mediators Inflamm. 8 (1999) 13-15
16. Dragomir A., and Roomans G.M. Increased chloride efflux in colchicine-resistant airway epithelial cell lines. Biochem. Pharmacol. 68 (2004) 253-261
17. Ben Chetrit E., and Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann. Rheum. Dis. 62 (2003) 916-919
18. Levy M., and Yaffe C. Testicular function in patients with familial Mediterranean fever on long-term colchicine treatment. Fertil. Steril. 29 (1978) 667-668
19. Ehrenfeld M., Levy M., Margalioth E.J., and Eliakim M. The effects of long-term colchicine therapy on male fertility in patients with familial Mediterranean fever. Andrologia 18 (1986) 420-426
20. Ehrenfeld M., Brzezinski A., Levy M., and Eliakim M. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br. J. Obstet. Gynaecol. 94 (1987) 1186-1191
21. Hastie S.B. Interactions of colchicine with tubulin. Pharmacol. Ther. 51 (1991) 377-401
22. Luduena R.F. Biochemestry of tubulin. In: Robert K., and Hyams J.S. (Eds). Microtubules (1979), Academic Press, New York 65-93
23. Ueda K., Cardarelli C., Gottesman M.M., and Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84 (1987) 3004-3008
24. Race T.F., Paes I.C., and Faloon W.W. Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am. J. Med. Sci. 259 (1970) 32-41
25. Wallace S.L., Omokoku B., and Ertel N.H. Colchicine plasma levels. Implications as to pharmacology and mechanism of action. Am. J. Med. 48 (1970) 443-448
26. Rochdi M., Sabouraud A., Girre C., Venet R., and Scherrmann J.M. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur. J. Clin. Pharmacol. 46 (1994) 351-354
27. Ehrenfeld M., Levy M., Sharon P., Rachmilewitz D., and Eliakim M. Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis. Dig. Dis. Sci. 27 (1982) 723-727 [familial Mediterranean fever]
28. Wallace S.L., Singer J.Z., Duncan G.J., Wigley F.M., and Kuncl R.W. Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J. Rheumatol. 18 (1991) 264-269
29. Sabouraud A., Chappey O., Dupin T., and Scherrmann J.M. Binding of colchicine and thiocolchicoside to human serum proteins and blood cells. Int. J. Clin. Pharmacol. Ther. 32 (1994) 429-432
30. Chappey O., Niel E., Dervichian M., Wautier J.L., Scherrmann J.M., and Cattan D. Colchicine concentration in leukocytes of patients with familial Mediterranean fever. Br. J. Clin. Pharmacol. 38 (1994) 87-89
31. Ertel N.H., and Wallace S.L. Measurement of colchicines in urine and peripheral leukocytes. Clin. Res. 19 (1971) 348
32. Chappey O.N., Niel E., Wautier J.L., Hung P.P., Dervichian M., Cattan D., et al. Colchicine disposition in human leukocytes after single and multiple oral administration. Clin. Pharmacol. Ther. 54 (1993) 360-367
33. Pascual E., and Castellano J.A. Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals. J. Rheumatol. 19 (1992) 600-603
34. Fordham J.N., Kirwan J., Cason J., and Currey H.L. Prolonged reduction in polymorphonuclear adhesion following oral colchicine. Ann. Rheum. Dis. 40 (1981) 605-608
35. Amoura Z., Schermann J.M., Wechsler B., Zerah X., and Godeau P. Transplacental passage of colchicine in familial Mediterranean fever. J. Rheumatol. 21 (1994) 383
36. Bennett E.L., Alberti M.H., and Flood J.F. Uptake of [3H]colchicine into brain and liver of mouse, rat, and chick. Pharmacol. Biochem. Behav. 14 (1981) 863-869
37. Drion N., Lemaire M., Lefauconnier J.M., and Scherrmann J.M. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J. Neurochem. 67 (1996) 1688-1693
38. Walasek E.J., Kocsis J.J., Leroy G.V., and Geiling E.M.K. Studies on the expression of radioactive colchicines. Arch. Int. Pharmacodyn. 125 (1960) 371-382
39. Sabouraud A., Cano N., and Scherrmann J.M. Radioimmunoassay of colchicines with antisera exhiting variable cross-reactivity. Ther. Drug Monit. 16 (1994) 179-185
40. de Lannoy I.A., Mandin R.S., and Silverman M. Renal secretion of vinblastine, vincristine and colchicine in vivo. J. Pharmacol. Exp. Ther. 268 (1994) 388-395
41. Speeg K.V., Maldonado A.L., Liaci J., and Muirhead D. Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. J. Pharmacol. Exp. Ther. 261 (1992) 50-55
42. Schonharting M., Mende G., and Siebert G. Metabolic transformation of colchicine, II. The metabolism of colchicine by mammalian liver microsomes. Hoppe Seylers Z. Physiol. Chem. 355 (1974) 1391-1399
43. Hasenmuller B., Schonharting M., and Siebert G. A study of microsomal oxidative functions with the aid of a series of N-colchiceyl derivatives. Hoppe Seylers Z. Physiol. Chem. 359 (1978) 725-731
44. Leighton J.A., Bay M.K., Maldonado A.L., Johnson R.F., Schenker S., and Speeg K.V. The effect of liver dysfunction on colchicine pharmacokinetics in the rat. Hepatology 11 (1990) 210-215
45. Leighton J.A., Bay M.K., Maldonado A.L., Schenker S., and Speeg K.V. Colchicine clearance is impaired in alcoholic cirrhosis. Hepatology 14 (1991) 1013-1015
46. Speeg K.V., Maldonado A.L., Liaci J., and Muirhead D. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology 15 (1992) 899-903
47. Siegal B., Zemer D., Shtrasburgh S., and Pras M. Cyclosporine toxicity in amyloidotic patients. Transplant. Proc. 19 (1987) 1544-1545
48. Cohen S.L., Boner G., Shmueli D., Yusim A., Rosenfeld J., and Shapira Z. Cyclosporin: poorly tolerated in familial Mediterranean fever. Nephrol. Dial. Transplant. 4 (1989) 201-204
49. Rochdi M., Sabouraud A., Baud F.J., Bismuth C., and Scherrmann J.M. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in 10 cases. Hum. Exp. Toxicol. 11 (1992) 510-516
50. Katz E.Z., Ehrenfeld M., Levy M., and Eliakim M. Plasma colchicine concentration in patients with recurrent polyserositis [familial Mediterranean fever] on long-term prophylaxis. Arthritis Rheum. 25 (1982) 227-231
51. Ben Chetrit E., Scherrmann J.M., Zylber-Katz E., and Levy M. Colchicine disposition in patients with familial Mediterranean fever with renal impairment. J. Rheumatol. 21 (1994) 710-713
52. Rudi J., Raedsch R., Gerteis C., Schlenker T., Plachky J., Walter-Sack I., et al. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment. Scand. J. Gastroenterol. 29 (1994) 346-351
53. Minetti E.E., and Minetti L. Multiple organ failure in a kidney transplant patient receiving both colchicines and cyclosporine. J. Nephrol. 16 (2003) 421-425
54. Caraco Y., Putterman C., Rahamimov R., and Ben Chetrit E. Acute colchicine intoxication-possible role of erythromycin administration. J. Rheumatol. 19 (1992) 494-496
55. Kuncl R.W., Duncan G., Watson D., Alderson K., Rogawski M.A., and Peper M. Colchicine myopathy and neuropathy. N. Engl. J. Med. 316 (1987) 1562-1568
56. Baker S.K., Goodwin S., Sur M., and Tarnopolsky M.A. Cytoskeletal myotoxicity from simvastatin and colchicines. Muscle Nerve 30 (2004) 799-802
57. Troger U., Lins H., Scherrmann J.M., Wallesch C.W., and Bode-Boger S.M. Tetraparesis associated with colchicines is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier. BMJ 331 (2005) 613
58. Rollot F., Pajot O., Chauvelot-Moachon L., Nazal E.M., Kelaidi C., and Blanche P. Acute colchicines intoxication during clarithromycin administration. Ann. Pharmacother. 38 (2004) 2074-2077
59. Baud F.J., Sabouraud A., Vicaut E., Taboulet P., Lang J., Bismuth C., et al. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments. N. Engl. J. Med. 332 (1995) 642-645